Anti-inflammatory Effect of Curcumin, Homotaurine, Vitamin D3 on Human Vitreous in Patients With Diabetic Retinopathy
Analysis of Soluble Mediators of Inflammation and Angiogenesis in the Vitreous of Patients With Diabetic Retinopathy Treated With Curcumin/Homotaurine/Vit. D3
Sponsor: Cliniche Humanitas Gavazzeni
A observational or N/A phase clinical study on Diabetic Retinopathy, this trial is completed. The trial is conducted by Cliniche Humanitas Gavazzeni and has accumulated 7 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
7 versions recorded-
Jan 2026 — Present [monthly]
Completed
-
Sep 2024 — Jan 2026 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2021 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Dec 2021 [monthly]
Completed
▶ Show 2 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Completed
-
Jun 2020 — Nov 2020 [monthly]
Completed
First recorded
Sep 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Cliniche Humanitas Gavazzeni
- Consorzio Sannio Tech
- FB VISION, Ascoli Piceno, Italy
- Humanitas Gradenigo - Torino
- University of Molise
- University of Roma La Sapienza
For direct contact, visit the study record on ClinicalTrials.gov .